This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Daniela Stefanie Thommen: Innovator in Cancer Therapy
Introduction
Daniela Stefanie Thommen is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer therapy through her innovative work. With a total of 2 patents, her research focuses on advancing treatment options for patients.
Latest Patents
Her latest patents include a groundbreaking invention related to combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists. This invention aims to enhance the efficacy of cancer treatments by employing these combination therapies, which are designed to activate T cells and inhibit the PD-1 axis, ultimately improving patient outcomes.
Career Highlights
Daniela is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her work at this esteemed organization has allowed her to collaborate with other experts in the field and contribute to innovative cancer therapies.
Collaborations
Some of her notable coworkers include Pablo Umana and Christian Klein. Their collaborative efforts have further advanced the research and development of effective cancer treatments.
Conclusion
Daniela Stefanie Thommen is a key figure in the realm of cancer therapy innovation. Her contributions through her patents and work at Hoffmann-La Roche Inc. highlight her commitment to improving treatment options for patients.